Ajinomoto Bio-Pharma Services, a US-based provider of biopharmaceutical contract development and manufacturing services, announced on Tuesday that it has been recognised with three CDMO Leadership Awards.

The company has received the honour in the categories Capabilities, Compatibility, and Expertise in both the Overall and Big Pharma respondent groups.

These awards are conferred by Life Science Leader magazine and Industry Standard Research. Seventy-two contract manufacturers were evaluated by 23 performance metrics in ISR's annual Contract Manufacturing Quality Benchmarking survey.